B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Nektar Therapeutics (NKTR – Research Report) on February 14 and set a price ...

In a report released today, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Healthcare Services (HCSG – Research Report) and ...

Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals conference call. (Operator Instructions) I will now hand the conference over to Vince Anzalone, Vice President of Investor Relations of ...

As a reminder, this conference call is being recorded today, February 5, 2025. I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ...

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared ...

Former India fast bowler and Lucknow Super Giants mentor Zaheer Khan has stressed the importance of having Mayank Yadav at his 150% fitness before fielding him in the upcoming IPL 2025. Listen to ...

Microwave-absorbing materials are widely utilized in military and civilian applications. Moreover, their environmental potential to refine electromagnetic pollution has promoted their importance. An ...

A long sprint from the deep. A euphoric leap. A jubilant scream. Is this the real Mayank Agarawal? Indeed, the situation demanded exultation. Abhilash Shetty had claimed Vidarbha’s last wicket ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Hold rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target of $236.00. The company ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of $20.00. The company’s shares closed yesterday at $7.00.